FDA Tells High Court Warning Letters Aren't Final Actions
The U.S. Food and Drug Administration argued to the U.S. Supreme Court last week that its warning letters do not constitute final agency actions subject to review in court, urging it...To view the full article, register now.
Already a subscriber? Click here to view full article